First Time Loading...

Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 133.46 USD 0.25% Market Closed
Updated: May 11, 2024

EV/S
Enterprise Value to Sales

22.9
Current
187
Median
7.5
Industry
Lower than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
22.9
=
Enterprise Value
8.1B
/
Revenue
329m
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
17.1
2-Years Forward
EV/S
10
3-Years Forward
EV/S
6.2

See Also

Discover More